Presentation is loading. Please wait.

Presentation is loading. Please wait.

Squamous-cell transformation in a patient with lung adenocarcinoma receiving erlotinib: Co-occurrence with T790M mutation  Diogo D.G. Bugano, Neda Kalhor,

Published byDarleen Francis Modified over 6 years ago

Similar presentations

Presentation on theme: "Squamous-cell transformation in a patient with lung adenocarcinoma receiving erlotinib: Co-occurrence with T790M mutation  Diogo D.G. Bugano, Neda Kalhor,"— Presentation transcript:

1 Squamous-cell transformation in a patient with lung adenocarcinoma receiving erlotinib: Co-occurrence with T790M mutation  Diogo D.G. Bugano, Neda Kalhor, Jianjun Zhang, Michele Neskey, William N. William  Cancer Treatment and Research Communications  Volume 4, Pages (January 2015) DOI: /j.ctrc Copyright © 2015 Elsevier Ltd Terms and Conditions

2 Figure 1 Pathology specimens. (A) Original pleural effusion from 2010 shows adenocarcinoma. (B) Cells in the original specimen are positive for TTF-1. (C) Re-biopsy after 2 lines of chemotherapy and 22 months of erlotinib is suggestive of squamous cell carcinoma which is TTF-1 negative (D) and p40 positive (E). Cancer Treatment and Research Communications 2015 4, 34-36DOI: ( /j.ctrc ) Copyright © 2015 Elsevier Ltd Terms and Conditions

Download ppt "Squamous-cell transformation in a patient with lung adenocarcinoma receiving erlotinib: Co-occurrence with T790M mutation  Diogo D.G. Bugano, Neda Kalhor,"

Similar presentations

What We Talk About When We Talk About Fat Evan D. Rosen, Bruce M. Spiegelman Cell Volume 156, Issue 1, Pages 20-44 (January 2014) DOI: 10.1016/j.cell.2013.12.012.

What We Talk About When We Talk About Fat Evan D. Rosen, Bruce M. Spiegelman Cell Volume 156, Issue 1, Pages (January 2014) DOI: /j.cell
Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages 410-421 (October 2013) DOI: 10.1016/j.ccr.2013.09.007.

Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr
Computational Modeling of Pancreatic Cancer Reveals Kinetics of Metastasis Suggesting Optimum Treatment Strategies Hiroshi Haeno, Mithat Gonen, Meghan.

Computational Modeling of Pancreatic Cancer Reveals Kinetics of Metastasis Suggesting Optimum Treatment Strategies Hiroshi Haeno, Mithat Gonen, Meghan.
Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages 275-291 (March 2014) DOI: 10.1016/j.stem.2014.02.006.

Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages (March 2014) DOI: /j.stem
The Microbiome and Cancer: Is the ‘Oncobiome’ Mirage Real? Ryan M. Thomas, Christian Jobin Trends in Cancer Volume 1, Issue 1, Pages 24-35 (September 2015)

The Microbiome and Cancer: Is the ‘Oncobiome’ Mirage Real? Ryan M. Thomas, Christian Jobin Trends in Cancer Volume 1, Issue 1, Pages (September 2015)
Healthy clocks, healthy body, healthy mind Akhilesh B. Reddy, John S. O’Neill Trends in Cell Biology Volume 20, Issue 1, Pages 36-44 (January 2010) DOI:

Healthy clocks, healthy body, healthy mind Akhilesh B. Reddy, John S. O’Neill Trends in Cell Biology Volume 20, Issue 1, Pages (January 2010) DOI:
Genetic testing for high-risk colon cancer patients1 William M. Grady Gastroenterology Volume 124, Issue 6, Pages 1574-1594 (May 2003) DOI: 10.1016/S0016-5085(03)00376-7.

Genetic testing for high-risk colon cancer patients1 William M. Grady Gastroenterology Volume 124, Issue 6, Pages (May 2003) DOI: /S (03)
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm Thierry Soussi, Klas G. Wiman Cancer Cell Volume 12, Issue 4, Pages 303-312 (October.

Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm Thierry Soussi, Klas G. Wiman Cancer Cell Volume 12, Issue 4, Pages (October.
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages 1590-1605 (November 2012) DOI: 10.1016/S0140-6736(12)60026-9.

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Assessment of chemotherapy strategy using bevacizumab for non-squamous non-small cell lung cancer in a real-world setting: A multi-institutional observational.

Assessment of chemotherapy strategy using bevacizumab for non-squamous non-small cell lung cancer in a real-world setting: A multi-institutional observational.
Ahsan R. Akram, John H. Reid, William Wallace, Simon W

Ahsan R. Akram, John H. Reid, William Wallace, Simon W
Case series of 21 patients with extrahepatic metastatic lobular breast carcinoma to the gastrointestinal tract  Noah Switzer, Andrew Lim, Lillian Du,

Case series of 21 patients with extrahepatic metastatic lobular breast carcinoma to the gastrointestinal tract  Noah Switzer, Andrew Lim, Lillian Du,
Is there a survival difference between single station and multi-station N2 disease in operated non-small cell lung cancer patients?  Tevfik Ilker Akcam,

Is there a survival difference between single station and multi-station N2 disease in operated non-small cell lung cancer patients?  Tevfik Ilker Akcam,
Epidermal Growth Factor Receptor Mutation in a Patient with Squamous Cell Carcinoma of the Lung: Who Should Be Tested Case Rep Oncol 2013;6:263-268 -

Epidermal Growth Factor Receptor Mutation in a Patient with Squamous Cell Carcinoma of the Lung: Who Should Be Tested Case Rep Oncol 2013;6:
Assessment of chemotherapy strategy using bevacizumab for non-squamous non-small cell lung cancer in a real-world setting: A multi-institutional observational.

Assessment of chemotherapy strategy using bevacizumab for non-squamous non-small cell lung cancer in a real-world setting: A multi-institutional observational.
Volume 111, Issue 6, Pages (June 1997)

Volume 111, Issue 6, Pages (June 1997)
Activity of trastuzumab-emtansine (TDM1) in HER2-positive breast cancer brain metastases: A case series  Kevin C. Keith, Yueh Lee, Matthew G. Ewend, Timothy.

Activity of trastuzumab-emtansine (TDM1) in HER2-positive breast cancer brain metastases: A case series  Kevin C. Keith, Yueh Lee, Matthew G. Ewend, Timothy.
Steroid-related emphysematous cystitis in an EGFR-mutant patient with lung adenocarcinoma while on gefitinib treatment  Diego Marquez-Medina, Sanjay Popat 

Steroid-related emphysematous cystitis in an EGFR-mutant patient with lung adenocarcinoma while on gefitinib treatment  Diego Marquez-Medina, Sanjay Popat 
Progressive brain metastases in an EGFR mutated adenocarcinoma of the lung: Response to gefitinib after progression on erlotinib  C. Leitner, R. von Moos,

Progressive brain metastases in an EGFR mutated adenocarcinoma of the lung: Response to gefitinib after progression on erlotinib  C. Leitner, R. von Moos,
Combined small cell lung cancer originated from small pure ground-glass nodule— Long-term observation after computed tomography screening  Kentaro Miura,

Combined small cell lung cancer originated from small pure ground-glass nodule— Long-term observation after computed tomography screening  Kentaro Miura,

Similar presentations

Ads by Google